Norton Johna
Known title: Senior VP, Global QualityCIK: 0001702471
Associated companies
Transaction History
| LLY | ▼ Sell | Open Market | 7,056 | $5.8M | 6/3/2024 | View on chart |
| LLY | ▲ Buy | Grant | 1,668 | $1.2M | 2/12/2024 | View on chart |
| LLY | ▲ Buy | Option Exercise | 1,268 | $0 | 2/1/2024 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 566 | $365K | 2/1/2024 | View on chart |
| LLY | ▼ Sell | Open Market | 1,647 | $738K | 6/15/2023 | View on chart |
| LLY | ▼ Sell | Open Market | 1,647 | $732K | 6/14/2023 | View on chart |
| LLY | ▼ Sell | Gift | 500 | $0 | 2/17/2023 | View on chart |
| LLY | ▲ Buy | Grant | 2,507 | $865K | 2/10/2023 | View on chart |
| LLY | ▲ Buy | Option Exercise | 2,102 | $0 | 2/1/2023 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 941 | $324K | 2/1/2023 | View on chart |
| LLY | ▲ Buy | Grant | 3,294 | $801K | 2/9/2022 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 1,194 | $293K | 2/1/2022 | View on chart |
| LLY | ▲ Buy | Option Exercise | 2,676 | $0 | 2/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Eli Lilly gets EMA backing for Foundayo obesity pill
The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.
Eli Lilly gets EMA backing for Foundayo obesity pill. The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.